| EPB104 | Prevalence and severity of nonalcoholic fatty liver disease in obese and non-obese patients with and without HIV infection in Asia | E-poster | Other non-communicable diseases |
| EPB105 | Associations between quality of oral health, HIV status, oral health practices and mental health status among adolescents in Nigeria: a cross-sectional study | E-poster | Other non-communicable diseases |
| EPB106 | Non-alcoholic to metabolic associated fatty liver disease: cardiovascular implications of a change in terminology in patients living with HIV | E-poster | Other non-communicable diseases |
| EPB107 | Genome-wide association study of plasma cholesterol and triglycerides among people living with HIV | E-poster | Metabolic, lipid and endocrine complications (including lipodystrophy) |
| EPB108 | Incidence of cardiometabolic outcomes among people living with HIV initiated on INSTI versus non-INSTI antiretroviral therapies | E-poster | Metabolic, lipid and endocrine complications (including lipodystrophy) |
| EPB109 | Lipid parameters and lipid modifying agent use in participants initiating F/TAF or F/TDF for PrEP in the DISCOVER trial | E-poster | Metabolic, lipid and endocrine complications (including lipodystrophy) |
| EPB110 | Weight gain after antiretroviral therapy initiation in people living with HIV | E-poster | Weight gain |
| EPB111 | Can ART switch mitigate or reverse INSTI-related weight or BMI gain in at-risk people living with HIV-1? | E-poster | Weight gain |
| EPB112 | Switching ART Regimens is associated with greater weight gain in people living with HIV | E-poster | Weight gain |
| EPB113 | Perceptions of health, body size and nutritional risk factors for obesity among people with and without HIV in South Africa | E-poster | Weight gain |